Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1,2-dimethylhydrazine in rat colons

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 11, 2007, Pages 2052-2057

  Kaneko, Takao ^a   Tahara, Shoichi ^a   Takabayashi, Fumiyo ^b  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

1,2 dimethylhydrazine; 8 oxo 2 deoxyguanosine; Carcinogenesis; Colon; Esculin; Oxidative DNA damage

Indexed keywords

1,2 DIMETHYLHYDRAZINE; 8 HYDROXYDEOXYGUANOSINE; COUMARIN DERIVATIVE; ESCULETIN; ESCULIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DNA DAMAGE; DRUG EFFECT; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTIOXIDANTS; CARCINOGENS; COLONIC NEOPLASMS; DEOXYGUANOSINE; DNA DAMAGE; ESCULIN; INTESTINAL MUCOSA; MALE; OXIDATION-REDUCTION; RANDOM ALLOCATION; RATS; RATS, INBRED F344; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UMBELLIFERONES;

EID: 36049006618     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.2052     Document Type: Article

References (43)

1. Witz G., Proc. Soc. Exp. Boil. Med., 198, 675-682 (1991).
2. Freeman B. A., Crapo J. D., Lab. Invest., 47, 412-426 (1982).
3. Kappus H., Arch. Toxicol., 60, 144-149 (1987).
4. Farber J. L., Kyle M. E., Coleman J. B., Lab. Invest., 62, 670-679 (1990).
5. Halliwell B., Dizdaroglu M., Free Radic. Res. Commun., 16, 75-87 (1992).
6. Cheng K. C., Cahill D. S., Kasai H., Nishimura S., Loeb L. A., J. Biol. Chem., 267, 166-172 (1992).
7. Moriya M., Proc. Natl. Acad. Sci. U.S.A., 90, 1122-1126 (1993).
8. Floyd R. A., Carcinogenesis, 11, 1447-1450 (1990).
9. Shibutani S., Takeshita M., Grollman A. P., Nature (London), 349, 431-433 (1991).
10. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y., Jpn. J. Cancer Res., 81, 213-215 (1990).
11. Nakae D., Kobayashi Y., Akai H., Andoh N., Satoh H., Ohashi K., Tsutsumi M., Konishi Y., Cancer Res., 57, 1281-1287 (1997).
12. Chung F. L., Xu Y., Carcinogenesis, 13, 1269-1272 (1992).
13. Pryor W. A., Stanley T. P., Blair E., Lipids, 11, 370-379 (1976).
14. Tsuda H., Ohshima Y., Nomoto H., Fujita K., Matsuda E., Iigo M., Takasuka N., Moore M. A., Drug Metab. Pharmacokinet., 19, 245-263 (2004).
15. Kanadaswami C., Lee L. T., Lee P. P., Hwang J. J., Ke F. C., Huang Y. T., Lee M. T., In Vivo, 19, 895-909 (2005).
16. Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., Thornes R. D., Drug Metab. Rev., 22, 503-529 (1990).
17. Neichi T., Koshihara Y., Murota S., Biochim. Biophys. Acta, 753, 130-132 (1983).
18. Hiramoto K., Ojima N., Sako K., Kikugawa K., Biol. Pharm. Bull., 19, 558-563 (1996).
19. Martín-Aragón S., Benedí J. M., Villar A. M., Gerontology, 44, 21-25 (1998).
20. Kaneko T., Tahara S., Takabayashi F., Biol. Pharm. Bull., 26, 840-844 (2003).
21. Kaneko T., Baba N., Matsuo M., Chem. Biol. Interact., 142, 239-254 (2003).
22. Kitagawa H., Noguchi M., Oncology, 51, 401-410 (1994).
23. Kaneko T., Tahara S., Takabayashi F., Harada N., Free Radic. Res., 38, 839-846 (2004).
24. James J. T., Autrup H., J. Natl. Cancer Inst., 70, 541-546 (1983).
25. LaMont J. T., O'Gorman T. A., Gastroenterology, 75, 1157-1169 (1978).
26. Bird R. P., Cancer Lett., 37, 147-151 (1987).
27. Bird R. P., Cancer Lett., 93, 55-71 (1995).
28. Roncucci L., Stamp D., Medline A., Cullen J. B., Bruce W. R., Hum. Pathol., 22, 287-294 (1991).
29. Takahashi S., Ogawa K., Ohshima H., Esumi H., Ito N., Sugimura T., Jpn. J. Cancer Res., 82, 135-137 (1991).
30. Pereira M. A., Barnes L. H., Rassman V. L., Kelloff G. V., Steele V. E., Carcinogenesis, 15, 1049-1054 (1994).
31. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
32. Valko M., Izakovic M., Mazur M., Rhodes C. J., Telser J., Mol. Cell. Biochem., 266, 37-56 (2004).
33. Fiala E. S., Sohn O. S., Hamilton S. R., Cancer Res., 47, 5939-5943 (1987).
34. Manju V., Balasubramaniyan V., Nalini N., Cell Mol. Biol. Lett., 10, 535-551 (2005).
35. Inagake M., Yamane T., Kitao Y., Oya K., Matsumoto H., Kikuoka N., Nakatani H., Takahashi T., Nishimura H., Iwashima A., Jpn. J. Cancer Res., 86, 1106-1111 (1995).
36. Takabayashi F., Harada N., Tahara S., Kaneko T., Hara Y., Pancreas, 15, 109-112 (1997).
37. Chang W. S., Lin C. C., Chuang S. C., Chiang H. C., Am. J. Chin. Med., 24, 11-17 (1996).
38. Pretlow T. P., O'Riordan M. A., Somich G. A., Amini S. B., Pretlow T. G., Carcinogenesis, 13, 1509-1512 (1992).
39. Tanaka T., Kojima T., Suzui M., Mori H., Cancer Res., 53, 3908-3913 (1993).
40. Kawamori T., Tanaka T., Hara A., Yamahara J., Mori H., Cancer Res., 55, 1277-1282 (1994).
41. Lee P. P., Ip M. M., Prostaglandins Leukot. Essent. Fatty Acids, 45, 21-31 (1992).
42. Blomgren H., Kling-Andersson G., Anticancer Res., 12, 981-986 (1992).
43. Lewis J. G., Adams D. O., Environ. Health Perspect., 76, 19-27 (1987).